Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study

Published:2019-11 Issue:6 Volume:13 Page:901-909.e3
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Baum Seth J.,Sampietro Tiziana,Datta Dev,Moriarty Patrick M.,Knusel Beat,Schneider Jingjing,Somaratne Ransi,Kurtz Christopher,Hohenstein Bernd

Funder

Amgen Inc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. European guidelines on cardiovascular disease prevention in clinical practice (version 2012);Perk;Eur Heart J,2012

2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014

3. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia--full report;J Clin Lipidol,2014

4. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals;Waters;Circulation,2009

5. Familial hypercholesterolemia;Goldstein,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins;Atherosclerosis Plus;2024-03

2. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia;Nature Reviews Cardiology;2023-06-15

3. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a);Current Atherosclerosis Reports;2023-06-05

4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

5. Hystrix cristata car accident induce acute coronary syndrome;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3